Daly, AF, Tichomirowa, MA, Petrossians, P, Heliövaara, E, Jaffrain-Rea, M-L, Barlier, A, Naves, LA, Ebeling, T
, Karhu, A, Raappana, A, Cazabat, L, De Menis, E, Fajardo Montanana, C, Raverot, G, Weil, RJ
, Sane, T, Maiter, D, Neggers, S, Yaneva, M, Tabarin, A, Verrua, E, Eloranta, E, Murat, A, Vierimaa, O, Salmela, PI, Emy, P, Toledo, RA, Isabel Sabate, M, Villa, C, Popelier, M, Salvatori, R, Jennings, J, Ferrandez Longas, A, Labarta Aizpun, JI, Georgitsi, M, Paschke, R, Ronchi, C
, Välimäki, M, Saloranta, C, De Herder, W, Cozzi, R, Guitelman, M, Magri, F, Lagonigro, MS, Halaby, G, Corman, V, Hagelstein, M-T, Vanbellinghen, J-F, Barra, GB, Gimenez-Roqueplo, A-P, Cameron, FJ, Borson-Chazot, F, Holdaway, I, Toledo, SPA, Stalla, GK, Spada, A, Zacharieva, S, Bertherat, J, Brue, T, Bours, V, Chanson, P
, Aaltonen, LA & Beckers, A 2010, '
Clinical Characteristics and Therapeutic Responses in Patients with Germ-Line AIP Mutations and Pituitary Adenomas: An International Collaborative Study',
Journal of Clinical Endocrinology and Metabolism, vol. 95, no. 11, pp. E373-E383.
https://doi.org/10.1210/jc.2009-2556